SCHEMBL14686138

SCHEMBL14686138

Cc1ccc(C)c(Nc2cc(N)c3nc([C@H]4CC[C@H](N)CC4)cn3n2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GALR2 O43603 2/20 0.35
▸ LMNA P02545 2/20 0.34
▸ GAA P10253 3/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ MAPT P10636 3/20 0.33
▸ TP53 P04637 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ RAPGEF4 Q8WZA2 1/20 0.32
▸ HSD17B10 Q99714 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3023450 0.85 RAB9A (0.33) GALR2LMNAGAASMN1; SMN2ALDH1A1
SCHEMBL14686229 0.80 EGFR (0.33) MAPT
SCHEMBL14686148 0.78 RAB9A (0.40) GALR2LMNAGAASMN1; SMN2ALDH1A1
SCHEMBL3025242 0.78 DPP4 (0.35) LMNASMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL14686135 0.77 IGF1R (0.35) —
SCHEMBL3019914 0.76 KARS1 (0.41) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL3019754 0.76 RIPK2 (0.35) SMN1; SMN2ALDH1A1NPC1RAB9AMAPT
SCHEMBL3024873 0.76 LYN (0.39) GAASMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL3019257 0.76 LYN (0.39) GAASMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL3022058 0.76 KARS1 (0.41) ALDH1A1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928879-B1 FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS BRISTOL MYERS SQUIBB CO (US) 2013-02-13 — — EP disclosed
Send feedback